Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Can multisource immediate release amodiaquine products qualify for BCS based biowaivers?

  • At: 2011 FIP Congress in Hyderabad (India)
  • Type: Poster
  • By: NAIR, Anita (Goethe University, Frankfurt Am Main, Germany)
  • Co-author(s): Dressman B, Jennifer (Goethe University, Frankfurt Am Main, Germany)
  • Abstract:

    Background information; Amodiaquine, frequently prescribed along with artesunate, is recommended for the treatment of uncomplicated falciparum malaria by the WHO. It is widely adopted for malarial treatment across sub-Saharan regions due to its high efficacy and tolerance. The biowaiver procedure based Biopharmaceutical Classification System (BCS)

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses